Document:

EXHIBIT
      10.6

    
Raw
      Plasma Supply Agreement 

    (Summary
      Translation) 

    December
      30, 2005

    

    Raw
      Plasma Supply Agreement

    

    Party
      A:
      Shandong Missile Biologic Products Co. Ltd.

    Party
      B:
      Shandong Province Zhangqiu Plasma Collection Station

    

    According
      to item 13 of the Regulation “Controlling of Blood Products”, a plasma
      collection station may only supply raw plasma to one blood products manufacturer
      under quality credential agreement, raw plasma supply to other manufacturers
      is
      forbidden. According to MOH standards, the plasma collection station and blood
      products manufacturer must sign an agreement for the supply of raw
      plasma.

    According
      to plasma regulations promulgated by the Bureau of Health, Shandong Province,
      Party B shall supply Party A with source plasma (hereafter referred to as
“plasma”). Both parties agree to the following terms and
      conditions:

    

    1.
      Quantity and Quality Standards of Plasma Supply

    I.
      Party
      B shall provide Party A with plasma collected from donors within the collection
      area who have passed all physical and biochemical tests.

    II.
      Major
      quality standards are as follows:

    
      	(1)  	
              HBsAg
                negative;

            

    

    
      	(2)  	
              Anti-HCV
                negative;

            

    

    
      	(3)  	
              Anti-HIV
                negative;

            

    

    
      	(4)  	
              ALT
                ≤ 25 units (Reit’s method);

            

    

    
      	(5)  	
              Syphilis
                serological test negative;

            

    

    
      	(6)  	
              Total
                plasma protein ≥ 55g/L (Biuret
                method);

            

    

    
      	(7)  	
              No
                germ contamination;

            

    

    
      	(8)  	
              Compliance
                with all other standards promulgated by the MOH over raw
                plasma;

            

    

    
      	(9)  	
              Appearance:
                plasma should be rice-yellow, clear, transparent liquid, without
                dissolved
                blood, milky feculence, fibrinogen clots, visible red blood cells
                or other
                impurities.

            

    

    III.
      The
      testing reagents used for HBsAg, Anti-HCV, Anti-HIV and syphilis testing must
      have passed “every-batch” inspection, and labeled with counterfeit-proof
      labels.

    IV.
      If
      the plasma sample fails to pass the double test performed by Party A, Party
      A
      shall immediately notify Party B to send technical personnel for further
      testing. If the sample fails to pass further testing, then the unit (bag of
      plasma) is disqualified, and Party A shall not make any payment. Party A should
      notify Party B of any testing failure in writing on a timely basis. The
      disqualified plasma should be sterilized on the spot and disposed of
      immediately, and Party A shall not dispose of disqualified plasma privately
      or
      send the plasma back to Party B.

    

    2.
      Labeling Plasma Samples

    I.
      Every
      bag of plasma should be labeled with the name, collection code, blood type,
      physical and biochemical test results of the donor, as well as the collection
      date.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    II.
      Every
      shipment of plasma should include a bill of lading, providing information on:
      the number of donors, the number of bags of plasma, as well as the biochemical
      test results. All these information should be internally
      consistent.

    III.
      Each
      bag of plasma must be appended with enough sample (about 13cm of conducting
      tube), labeled with the corresponding plasma collection code. The sample plasma
      must be consistent with the plasma contained in the bag. Plasma with sample
      label absent, unclarity or lacking of code or inconsistency with records is
      treated as disqualified, plasma would be disposed of in the way described in
      1(IV).

    IV.
      Collection coding: continual coding within the same year from January 1 to
      December 31, without repeating or skipping. Codes take the form of
“03000001-03015551”, with “03” representing the year 2003, and 000001-015551
      specifying plasma man collection unit. Thus the number of collections taken
      in
      the year 2003 was 15551.

    

    3.
      Pricing and Transportation

    I.
      The
      pricing of plasma complies with regulations promulgated by the provincial Bureau
      of Health and the provincial Pricing Bureau. The current unit price of qualified
      plasma is RMB $235,000 per ton, balance settled at the end of every month.
      If
      national plasma pricing standards should shift, both parties shall negotiate
      on
      new prices.

    II.
      If
      the protein level of the plasma is lower than 55g/L, the price is reduced by
      2%
      for every 1g/L lower than the standard. The protein level here referred to
      is
      the average protein level of the annual supply, calculated at the end of each
      year.

    III.
      Party A is responsible for the transportation of plasma. Party B shall pack
      the
      plasma and load the transporting vehicles as Party A requires. After all
      relevant personnel have confirmed the information in the bill of lading,
      delegates of both parties shall sign to certify delivery.

    IV.
      Party
      A visits Party B to collect plasma and make payment on a regular basis. Payment
      for each batch of plasma are made at the delivery of the next
      batch.

    

    4.
      Other
      Specifications

    I.
      The
      plasma collected must be stored in freezing temperature by each donar. No cross
      mixing of plasma should occur.

    II.
      After
      collection, the plasma should be immediately stored in a fridge or cold storage
      room at -30°C, to ensure freezing within 6 hours.

    III.
      Each
      bag contains 580ml of plasma, or equivalent to 600 g in weight. The net weight
      of each bag of plasma is calculated in the following way: gross weight - bag
      weight - sample tube weight ≈ net weight.

    IV.
      Party
      B may only supply plasma to Party A. No supplying to any third party should
      take
      place.

    V.
      Party
      A is obliged to offer complete technical guidance to Party B and ensure quality
      control.

    

    5.
      Any
      details not specified in this Agreement shall be negotiated between both
      parties.

    

    6.
      There
      are five copies of this Agreement: one held by either party, and one submitted
      to the provincial, municipal and county Bureau of Health,
      respectively.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    7.
      This
      Agreement becomes valid after legal delegates of both parties have signed and
      stamped. The agreement will end on December 31, 2006.

    

    Party
      A

    Legal
      Delegate: (signature and stamp)

    January
      1, 2006

    

    Party
      B

    Legal
      Delegate: (signature and stamp)

    January
      1, 2006Exhibit 10.7 

(English Translation) 

Employment Agreement 

	n	
Contract effective date: March 8, 2007

	
	 
	
      n     	
Signed between China Biologic Products, Inc and Stanley Wong

	
	 
	
      n	
Title of employment: Chief Executive Officer

	
	 
	
      n	
Place of employment: Taian City, Shandong Province, PRC

	
	 
	
      n	
Duties: Lead the Company day-to-day operations, handle matters relating to regulators, intermediaries and institutional investors, ensure compliance of Sox requirement in 2007, responsible for capital
sourcing and investment, lead and coordinate the decision on funding, operations and management in the company and its subsidiaries, co-ordinate listing work. Assist and ensure subsidiary’s CEO to implement financial and internal controls
matter.

	
	 
	
      n	
Probation period: one months

	
	 
	n	
Salary: HK$80,000 and RMB20,000 per month on a 13 months basis.

	
	 
	n	
Working hours: 0830 to 1700 Monday to Friday

	
	 
	n	
Bonus: at Board of Directors’ discretion.

	
	 
	
      n	
Paid leave: 18 days

	
	 
	
      n	
Tax: HK and PRC tax are borne by employee

	
	 
	
      n	
Other benefit: round trip ticket to HK each month

	
	 
	
      n	
Shares/options: Eligible as declared by BOD

	
	 
	
      n	
Contract signed by

	
	 

	/s/
    Zhao Chao Min
	                         
		 /s/
    Stanley Wong

	
Zhao Chao Min
		 
		
Stanley Wong
	
	
director of China Biologic Products, Inc.Exhibit 10.8

STRICTLY PRIVATE AND CONFIDENTIAL

CHINA BIOLOGIC PRODUCTS, INC. 

FORM OF EMPLOYMENT AGREEMENT

THIS AGREEMENT is made on the date of _______________

BETWEEN

(1)           China Biologic Products, Inc. whose registered office is situated at No. 14 East Hushan Road, Taian City, Shandong, People’s Republic of China 271000 (the
“Company”), and 

(2)           ____________ (hereunder called the “Employee”). 

WHEREAS the Company is desirous of employing the Employee as a ___________ of the Company and the Employee is desirous of being so employed subject to and on the following
terms and conditions. 

NOW IT IS HEREBY AGREED as follows:

	
(1)          	
APPOINTMENT

	
	 
	 	
The Company shall employ the Employee and
    the Employee shall serve the Company as a ___________ of
    the Company.

	
	 
	
(2)	
DURATION

	
	 
	 	
(a)           

		The employment of the Employee hereunder
    shall commence on _____________ (the “Commencement
    Date”) and shall continue thereafter until being terminated in accordance
    with the provisions of this Agreement.
	 
	
(3)	
DUTIES

	
	 
	 	
(a) 

		The Employee shall,
	 
	 	 	(i) 	
serve as a ___________ of the Company and shall discharge and perform all his/her duties as such and discharge and perform such other duties as the
Company may from time to time assign to him/her;

	
	 
	 	 	(ii)           	
devote himself/herself and his/her attention
    to the business of the Company as shall reasonably required for the due discharge
    and performance of his/her duties hereunder;

	
	 
	 	 	(iii)	
 in all respects observe and comply with all
    relevant laws, regulations, rules, code of conducts, guidelines, procedures,
    restrictions, directions for the time being in force applicable to and governing
    the regulated activities

	
	 

	 	 	 	 of the Company and all
          such regulations, rules, code of conducts, guidelines, procedures,
          restrictions, directions from time to time imposed by the Company relating
          to or in respect of the Company’s business and/or the Employee’s
          duties hereunder; and

	 
	 	 	
(iv)        	
use all reasonable endeavors to promote the best interests of the Company and its business.

	
	 
	 	
(b)          	
The Employee shall attend at the office of the Company or at such other places as his/her duties or as the Company may require and shall not absent himself/herself during the normal working hours except in the case
of illness or incapacity.

	
	 
	
(4)          	
REMUNERATION AND TAX

	
	 
	 	
(a)	
During the continuance in force of his/her employment hereunder, the Company will pay the Employee a monthly remuneration of ______ in arrears normally at
the end of each month, subject to such necessary adjustment if the Employee has not worked for a complete month for any particular month.

	
	 
	 	
(b)	
The Company will pay the Employee a [guaranteed/discretionary] bonus of ______________ on 31st December each year.

	
	 
	 	
(c)	
The Employee shall be responsible for his/her own salary and/or income tax liabilities wherever and whenever imposed upon or resulting from his/her employment and in respect of all his/her income
hereunder.

	
	 
	
(5)	
EMPLOYEE BENEFITS

	
	 
	 	
(a)	
Mandatory Provident Fund Scheme

	
	 
	 	 	
The Employee will participate in the Company’s Mandatory Provident Funds Scheme subject to the terms and conditions governing such scheme.

	
	 
	 	
(b)	
Medical Benefits

	
	 
	 	 	
The Employee will be covered under the Company’s Medical Insurance Scheme subject to the terms and conditions governing such scheme.

	
	 
	 	
(c)	
Bonus and others

	
	 
	 	 	
The Employee may be granted bonus in such amount and/or such other benefits as the Company may at its absolute discretion from time to time provide.

	
	 
	
(6)	
ANNUAL LEAVE

	
	 
	 	
(a)	
The Employee shall be entitled to __________ working days of paid leave per annum in addition to the normal statutory holidays. Leave is to be taken at
such

	
	 

	 	
 

		times and intervals as may be agreed
    by the Company having regard to the workload of the Employee and needs of
    the Company.
	 
	 	
(b)          	
Accumulation of leave is permitted and leave not taken in any year shall be carry- forward to the next year.

	
	 
	
(7)          	
BUSINESS EXPENSES

	
	 
	 	
The Company will reimburse the Employee all out-of-pocket expenses necessarily incurred by the Employee in the discharge and performance of his/her duties hereunder upon production of such appropriate receipts or
vouchers as the Company may reasonably require from time to time.

	
	 
	
(8)	
NON-DISCLOSURE

	
	 
	 	
(a)	
The Employee shall not either during the continuance of his/her employment hereunder or thereafter except in the proper course in discharge and performance of his/her duties hereunder divulge to any person
whosoever or company whatsoever and shall use his/her best endeavours to prevent the unauthorised publication or disclosure of any information concerning the business or finances of the Company or any of its clients or customers or any of the
organizations, dealings, transactions, operations, practice or affairs of the Company or any of its clients or customers which may come to his/her knowledge during or in the course of his/her employment hereunder.

	
	 
	 	
(b)	
The Employee hereby acknowledged that, the computer systems and any other assets of the Company or any other member of the Company is the exclusive property of the Company (including without limit, the software and
all information stored therein). All the Employee’s work products as well as datas, information and documentation in such computer systems, including but without limit, intellectual property rights, shall remain the sole and exclusive property
of the Company and disclosure, retention or destruction of such any of such products, datas, information or documentation is hereby prohibited.

	
	 
	
(9)	
RESTRICTION AFTER TERMINATION

	
	 
	 	
(a)	
Upon the termination of his/her employment hereunder for any cause or by any means whatsoever, the Employee shall not for a period of 45 days next thereafter, directly or indirectly,

	
	 
	 	 	
(i)          	
canvass or solicit by any means whatsoever for himself/herself or any other person, firm or company, any person or company who shall at any time during the continuance of his/her employment hereunder have been a
client or customer of the Company or any other member of the Company or endeavour to take away such client or customer from the Company or any other member of the Group, or

	
	 

	 	 	
(ii)         	
solicit or encourage any employee of the Company or any other member of the Group to leave the employ of the Company or such other member of the Group.

	
	 
	                	
(b)          	
After the termination of his/her employment hereunder for any cause or by any means whatsoever, the Employee shall not at any time or for any purpose use the name of the Company or any other member of the Company
in connection with his/her own or any other name in any way calculated to suggest that he/she is or has been connected with the business of the Company or any other member of the Group nor in any way hold himself/herself out as having or having had
any such connection and shall not use any information concerning the Company or any other member of the Group which he/she may have acquired in the course of or as incident to his/her employment hereunder for his/her own benefit or to the detriment
or intended or probable detriment to the Company or any other member of the Group.

	
	 

	
(10)          	
NON-COMPETITION

	
	 
	 	
During the course of the Employee’s employment hereunder. the Employee shall not without the prior approval of the Company engage or be concerned or interested directly or indirectly as principal, agent,
employee or otherwise (except in his/her capacity employed hereunder) in the similar business or activities being carry on by the Company or be personally employed or engaged with or without any consideration in any capacity whatsoever in or in
connection with any business whatsoever other than the business of the Company.

	
	 
	
(11)	
TERMINATION

	
	 
	 	
The employment of the Employee hereunder may be terminated at any time.

	
	 
	 	
(a)          	
by either party hereto giving to the other
    not less than _________ month(s)’s
    prior notice in writing to that effect or paying to the other a sum  equal
    to not less than ______ month(s)’s salary in lieu of such notice; or

	
	 
	 	
(b)	
by the Employee without any prior notice or payment in lieu thereof.

	
	 
	 	If the Employee is also appointed
        as a director of the Company, upon the termination of his/her employment
        hereunder, he/she shall at the time of such termination automatically
        cease to be the director of the Company without any claim, compensation
        or payment of any nature whatsoever by reason thereof.

	 
	
(12)	
SEVERABILITY

	
	 
	 	
If at any time any provision of this Agreement or any part of such provision becomes invalid, illegal, unenforceable or incapable of performance in any respect, the validity, legality, enforceability or performance
of the remaining provisions hereof or such

	
	 

	 	
remaining part of such provision (as the case may be) shall not thereby in any way be affected or impaired.

	
	 
	
(13)          	
ENTIRE AGREEMENT

	
	 
	 	
This Agreement constitutes the entire agreement and understanding between the parties hereto in connection with the subject matter of this Agreement and supersedes all previous (if any) proposals, representations,
warranties, undertakings or agreements relating thereto whether oral, written or otherwise and neither party hereto has relied on (if any) such proposals, representations, warranties, undertakings or agreements in entering into this
Agreement.

	
	 
	
(14)	
GOVERNING LAW

	
	 
	 	
This Agreement shall be governed and construed according to the laws of Hong Kong Special Administrative Region (“Hong Kong”) and the parties hereto hereby submit to the non-exclusive jurisdiction of the
Hong Kong courts.

	
	 
	 
	 

	
SIGNED BY
		 	
SIGNED BY
	
	
For and on behalf of
		 	 

	
	China Biologic Products, Inc.

	
	 

	
	 

	
	 

	
	 	          	 

	
	
Authorised Signatory
		 	
[EMPLOYEE]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}]]